CorreGene Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Investors
-
8
CorreGene General Information
Description
Developer of a gene biotechnology designed to provide innovative therapies for solid tumors and chronic infections. The company utilizes a proprietary affinity optimization platform, TCR cloning, high-throughput discovery, process development, and analytical quality control, enabling the oncology and infectious disease markets to access targeted immunotherapy products for complex medical conditions.
Contact Information
Website
www.corregene.comCorporate Office
- 3rd Floor, North Building, Changfa International Precision Medicine Acceleration Center
- Number 21, Xihuan Road, Life Science Park, Changping District
- Beijing, 102206
- China
Corporate Office
- 3rd Floor, North Building, Changfa International Precision Medicine Acceleration Center
- Number 21, Xihuan Road, Life Science Park, Changping District
- Beijing, 102206
- China
CorreGene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 20-May-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Jul-2022 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 02-Nov-2021 | $15.6M | $15.6M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Dec-2019 | Completed | Generating Revenue |
CorreGene Signals
CorreGene Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ennovation Ventures | Venture Capital | Minority | ||
| Zhuhai Xinrui Medical Equity Investment Management | Growth/Expansion | Minority | ||
| CDBI Partners | Venture Capital | Minority | ||
| Chang Development | Corporation | Minority | ||
| Longmen Capital | Venture Capital | Minority |
CorreGene FAQs
-
When was CorreGene founded?
CorreGene was founded in 2016.
-
Where is CorreGene headquartered?
CorreGene is headquartered in Beijing, China.
-
What is the size of CorreGene?
CorreGene has 16 total employees.
-
What industry is CorreGene in?
CorreGene’s primary industry is Biotechnology.
-
Is CorreGene a private or public company?
CorreGene is a Private company.
-
What is CorreGene’s current revenue?
The current revenue for CorreGene is .
-
How much funding has CorreGene raised over time?
CorreGene has raised $30.5M.
-
Who are CorreGene’s investors?
Ennovation Ventures, Zhuhai Xinrui Medical Equity Investment Management, CDBI Partners, Chang Development, and Longmen Capital are 5 of 8 investors who have invested in CorreGene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process